Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
Résumé
Correspondance
Domaines
Sciences du Vivant [q-bio]Origine | Publication financée par une institution |
---|
Loading...